Steven Cohen Novo Nordisk A S Transaction History

Point72 Asset Management, L.P.

$36 Billion
Q2 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Novo Nordisk A S stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 960,854 shares of NVO stock, worth $103 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

960,854

Previous 960,854 -0.0%

Holding current value

$103 Million

Previous $137 Million -0.0%

% of portfolio

0.38%

Previous 0.38%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $118 Million - $141 Million	960,854 New	960,854 $137 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $10,450 - $11,567	67 New	67 $10,000
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $57.7 Million - $68 Million	-558,530 Reduced 95.51%	26,270 $2.93 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $54.4 Million - $65.8 Million	584,800 New	584,800 $64.9 Million
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $2.9 Million - $3.8 Million	-58,620 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $2.92 Million - $3.42 Million	58,620 New	58,620 $3.39 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $38.9 Million - $43.6 Million	-831,104 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $2.79 Million - $3.16 Million	-60,102 Reduced 6.74%	831,104 $43.5 Million
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $37 Million - $42.1 Million	891,206 New	891,206 $41.1 Million
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $14.3 Million - $17.2 Million	-295,863 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $6.96 Million - $7.87 Million	146,463 Added 98.03%	295,863 $15.9 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $6.15 Million - $7.35 Million	149,400	149,400 $7.19 Million

Others Institutions Holding NVO

# of Institutions

1,951

Shares Held

320M

Call Options Held

5.22M

Put Options Held

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $243B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account